Predicting Parameters for Successful Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock.

Echocardiography Mechanical circulatory support Pulmonary artery catheter Refractory cardiogenic shock Veno-arterial extracorporeal membrane oxygenation weaning

Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
02 2021
Historique:
received: 07 07 2020
revised: 24 09 2020
accepted: 23 10 2020
pubmed: 3 12 2020
medline: 2 7 2021
entrez: 2 12 2020
Statut: ppublish

Résumé

Percutaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is utilized for patients with cardiogenic shock or cardiac arrest. However, the procedure protocol for weaning from VA-ECMO has not been well established. The present study aimed to determine the usefulness of echocardiographic and pulmonary artery catheter parameters for predicting successful weaning from VA-ECMO in patients with refractory cardiogenic shock. We retrospectively studied 50 patients who were hospitalized and supported by VA-ECMO for >48 h between January 2013 and March 2017. Patients successfully weaned from VA-ECMO without reintroduction of VA-ECMO or left ventricular assist device implantation were defined as 30 day survivors. Echocardiographic and pulmonary artery catheter parameters were evaluated when ECMO flow was limited to a maximum of 1.5-2.0 L/min. Twenty-four patients were successfully weaned from VA-ECMO, whereas 26 were not. Fractional shortening, corrected left ventricular ejection time (LVETc, defined as LVET divided by the square root of heart rate), left ventricular outflow tract velocity time integral, and LVETc divided by pulmonary artery wedge pressure (PAWP) were significantly larger in the 30 day survivor groups. Multivariable analysis revealed LVETc∕PAWP as a significant independent predictor of successful weaning (LVETc∕PAWP, odds ratio 0.82, 95% confidence interval 0.71-0.94, P = 0.005). Receiver operating characteristic curve analysis revealed 15.9 as the optimal LVETc∕PAWP for predicting successful weaning (area under the curve 0.82). The present findings indicate that LVETc∕PAWP is a potential predictor of successful weaning from VA-ECMO.

Identifiants

pubmed: 33264500
doi: 10.1002/ehf2.13097
pmc: PMC7835592
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

471-480

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

J Heart Lung Transplant. 2010 Jan;29(1):66-71
pubmed: 19837609
Circ J. 2002 Feb;66(2):133-44
pubmed: 11999637
ESC Heart Fail. 2021 Feb;8(1):471-480
pubmed: 33264500
N Engl J Med. 2012 Oct 4;367(14):1287-96
pubmed: 22920912
Am J Cardiol. 2018 Dec 15;122(12):2014-2017
pubmed: 30297267
Crit Care. 2016 Apr 05;20:80
pubmed: 27044572
J Am Soc Echocardiogr. 2018 Feb;31(2):169-179
pubmed: 29079045
Intensive Care Med. 2015 May;41(5):902-5
pubmed: 25619488
Eur Heart J. 2005 Oct;26(20):2185-92
pubmed: 16014643
Intensive Care Med. 2018 Jun;44(6):717-729
pubmed: 29450594
Pediatr Crit Care Med. 2010 Mar;11(2):234-8
pubmed: 19794327
Circulation. 1968 Feb;37(2):149-59
pubmed: 5640345
J Thorac Cardiovasc Surg. 2013 Dec;146(6):1474-9
pubmed: 23993027
Circ Res. 1958 May;6(3):319-25
pubmed: 13523814
J Card Fail. 2019 May;25(5):364-371
pubmed: 30858119
Circ Heart Fail. 2010 Jan;3(1):149-56
pubmed: 19903930
Intensive Care Med. 2017 Apr;43(4):592-594
pubmed: 28011989
Anaesth Crit Care Pain Med. 2018 Jun;37(3):259-268
pubmed: 29033360
Perfusion. 2019 Mar;34(2):98-105
pubmed: 30112975
Intensive Care Med. 2018 Jun;44(6):760-773
pubmed: 29767322
ASAIO Trans. 1991 Jul-Sep;37(3):M420-1
pubmed: 1751217
Crit Care Med. 2008 May;36(5):1404-11
pubmed: 18434909
Eur Heart J. 2019 Aug 21;40(32):2671-2683
pubmed: 31274157
J Thorac Cardiovasc Surg. 2010 Feb;139(2):302-11, 311.e1
pubmed: 20106393
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2769-78
pubmed: 24814488
Intensive Care Med. 2011 Nov;37(11):1738-45
pubmed: 21965097
Intensive Care Med. 2017 Sep;43(9):1306-1318
pubmed: 28470346
J Am Coll Cardiol. 2003 Jan 15;41(2):197-203
pubmed: 12535808
Circulation. 1977 Aug;56(2):146-58
pubmed: 872305
PLoS One. 2012;7(8):e42687
pubmed: 22870340
J Appl Physiol. 1963 Sep;18:919-23
pubmed: 14063261
Ann Cardiothorac Surg. 2019 Jan;8(1):E1-E8
pubmed: 30854330
Am J Hypertens. 2014 May;27(5):702-9
pubmed: 24108863
J Cardiothorac Vasc Anesth. 2015 Aug;29(4):906-11
pubmed: 25836952

Auteurs

Kenichiro Sawada (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Shoji Kawakami (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.

Shunsuke Murata (S)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Japan.

Kunihiro Nishimura (K)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Japan.

Yoshio Tahara (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.

Hayato Hosoda (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.

Takahiro Nakashima (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.

Yu Kataoka (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Yasuhide Asaumi (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.

Teruo Noguchi (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.

Masaru Sugimachi (M)

Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, Suita, Japan.

Tomoyuki Fujita (T)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.

Junjiro Kobayashi (J)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH